首页> 外文OA文献 >Assessment of the Efficacy of ReoGo-J Robotic Training Against Other Rehabilitation Therapies for Upper-Limb Hemiplegia After Stroke: Protocol for a Randomized Controlled Trial
【2h】

Assessment of the Efficacy of ReoGo-J Robotic Training Against Other Rehabilitation Therapies for Upper-Limb Hemiplegia After Stroke: Protocol for a Randomized Controlled Trial

机译:评估中风后肢体偏瘫其他康复疗法的Reogo-J机器人训练的功效:随机对照试验的议定书

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Stroke patients experience chronic hemiparesis in their upper extremities leaving negative effects on quality of life. Robotic therapy is one method to recover arm function, but its research is still in its infancy. Research questions of this study is to investigate how to maximize the benefit of robotic therapy using ReoGo-J for arm hemiplegia in chronic stroke patients.Methods: Design of this study is a multi-center parallel group trial following the prospective, randomized, open-label, blinded endpoint (PROBE) study model. Participants and setting will be 120 chronic stroke patients (over 6 months post-stroke) will be randomly allocated to three different rehabilitation protocols. In this study, the control group will receive 20 min of standard rehabilitation (conventional occupational therapy) and 40 min of self-training (i.e., sanding, placing and stretching). The robotic therapy group will receive 20 min of standard rehabilitation and 40 min of robotic therapy using ReoGo®-J device. The combined therapy group will receive 40 min of robotic therapy and 20 min of constraint-induced movement therapy (protocol to improve upper-limb use in ADL suggests). This study employs the Fugl-Meyer Assessment upper-limb score (primary outcome), other arm function measures and the Stroke Impact Scale score will be measured at baseline, 5 and 10 weeks of the treatment phase. In analysis of this study, we use the mixed effects model for repeated measures to compare changes in outcomes between groups at 5 and 10 Weeks. The registration number of this study is UMIN000022509.Conclusions: This study is a feasible, multi-site randomized controlled trial to examine our hypothesis that combined training protocol could maximize the benefit of robotic therapy and best effective therapeutic strategy for patients with upper-limb hemiparesis.
机译:背景:中风患者在其上肢体验慢性偏瘫,留下对生命质量的负面影响。机器人治疗是一种恢复ARM功能的方法,但其研究仍处于初期阶段。本研究的研究问题是调查如何使用慢性中风患者的Reogo-J用于臂偏瘫的机器人治疗的好处。方法:本研究的设计是一个多中心并联组试验,后期,随机,开放标签,盲终点(探测)研究模型。参与者和环境将是120例慢性中风患者(中风后6个月)将随机分配给三种不同的康复协议。在这项研究中,对照组将获得20分钟的标准康复(常规职业治疗)和40分钟的自我训练(即打磨,放置和伸展)。机器人治疗组将获得20分钟的标准康复和使用Reogo®-J设备的机器人治疗40分钟。合并的治疗组将获得40分钟的机器人治疗和20分钟的约束诱导的运动疗法(协议改善ADL中的上肢使用)。本研究采用Fugl-Meyer评估高肢评分(主要结果),其他ARM功能措施和中风冲击比分将在基线,5和10周的治疗阶段测量。在分析本研究中,我们使用混合效应模型进行重复措施,以比较5至10周的群体之间的成果的变化。本研究的注册号是UMIN000022509.Conclusions:本研究是一个可行的多场随机对照试验,以检查我们的假设,即组合培训协议可以最大限度地提高机器人治疗和最佳有效的肢体血管患者患者的有效治疗策略的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号